Efecto de la cirugía de catarata en la sensibilidad al contraste y la calidad de vida de pacientes con diferentes tipos de catarata
Effect of cataract surgery on contrast sensitivity and quality of life in patients with different types of cataract
Objective: To determine the effect of cataract surgery on contrast sensitivity and quality of life of patients with different types of cataract. Methods: Prospective study with a preand post-test design in patients with indication for cataract surgery by phacoemulsification. Best-corrected visual acuity (BCVA) at different contrast levels and vision-related quality of life (V-RQOL) were evaluated before and 30 days after surgery. The study population was divided into 3 comparative groups according to the type of predominant cataract following the Lens Opacities Classification System III: nuclear, cortical and posterior subcapsular (PSC). Results: Seventy-eight eyes of 78 patients with a mean age of 69.3 ± 9.6 (51-86) years were included. In the preoperative period, low contrast sensitivity was slightly affected in the nuclear group and severely affected in the PSC group. V-RQOL limitations scale was significantly lower for the PSC group compared to the nuclear group (0 [0-15.6 vs. 6.2 [0-12.5; p = 0.040). After surgery, BCVA and contrast sensitivity improved in the three study groups. The most significant changes were observed in the PSC group. V-RQOL improvement was positively related to visual acuity gain in high and low contrast in the three study groups. Conclusion: Cataract surgery significantly improved contrast sensitivity and quality of life of all patients, especially in those with PSC opacity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.